Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

By | March 1, 2021
Scientists compared the in vitro efficacy and cytotoxicity profiles of PF-00835231 and remdesivir in two human model systems for SARS-CoV-2 infection.